Heterogeneous delayed enhancement of hepatic parenchyma after intravenous infusion of sonographic contrast agent: A new hypothesis

被引：10

作者：

Caruso G. ^{[1
,3
]}

Martegani A. ^{[2
]}

Aiani L. ^{[2
]}

Borghi C. ^{[2
]}

Verderame F. ^{[1
]}

Campisi A. ^{[1
]}

Salvaggio G. ^{[1
]}

Lagalla R. ^{[1
]}

Cardinale A.E. ^{[1
]}

机构：

[1] Department of Radiology, University of Palermo, Palermo

[2] Department of Radiology, Hospital Valduce, Como

[3] I-90144 Palermo, Via Liguria

来源：

La radiologia medica | 2007年 / 112卷 / 1期

关键词：

Liver; Microbubbles; Ultrasound;

D O I：

10.1007/s11547-007-0120-1

中图分类号：

学科分类号：

摘要：

Purpose. The aim of this paper was to report a heterogeneous latephase hepatic enhancement pattern observed after administration of a sonographic contrast agent and to present an aetiological hypothesis for the phenomenon. Materials and methods. A total of 1,729 (1,012 women and 717 men; age range 28-82; mean age 51) patients underwent contrastenhanced sonography of the liver. The examination was performed with a low mechanical index (MI <0.09) after injection of sulphur-hexafluoride-filled microbubbles, using different sonographic equipment and different contrast-specific algorithms. Results. Heterogeneous delayed liver enhancement was observed in six patients in the late phase (180 s), with the presence of multiple, partially confluent, hyperechoic areas peripheral to the portal vessels. The pattern appeared spontaneously between 1 and 4 h after the examination and was associated with the presence of an anomalous echogenicity in the superior mesenteric vein. No patient experienced adverse reactions. Conclusions. The phenomenon of heterogeneous hepatic enhancement may be related to gas from the intestinal microcirculation being transported to via the enteroportal circulation and becoming trapped in the hepatic sinusoids. © 2007 Springer-Verlag.

引用

页码：56 / 63

页数：7

共 21 条

[1]

Blomley M., Cosgrove D., Microbubble echo-enhancers: A new direction for ultrasound?, Lancet, 349, pp. 1855-1856, (1997)

[2]

Kono Y., Steinbach G.C., Peterson T., Et al., Mechanism of parenchymal enhancement of the liver with a microbubble-based US contrast medium: An intravital microscopy study in rats, Radiology, 224, pp. 253-257, (2002)

[3]

Eyding J., Wilkening W., Postert T., Brain perfusion and ultrasonic imaging techniques, Eur J Ultrasound, 16, pp. 91-104, (2002)

[4]

Bokor D., Diagnostic efficacy of SonoVue, Am J Cardiol, 86, pp. 19-24, (2000)

[5]

Okada M., Albrecht T., Blomley M.J., Et al., Heterogeneous delayed enhancement of the liver after ultrasound contrast agent injection-a normal variant, Ultrasound Med Biol, 28, pp. 1089-1092, (2002)

[6]

Borghi C., Aiani L., Sopransi M., Et al., Current state of the use of sonographic contrast agents with low acoustic pressure techniques in the study of focal liver lesions, Radiol Med, 107, pp. 174-186, (2004)

[7]

Whittingham T.A., Contrast-Specific Imaging Tecniques: Technical Perspective, pp. 43-70, (2005)

[8]

Bryant T.H., Blomley M.J., Albrecht T., Et al., Improved characterization of liver lesions with liver-phase uptake of liver-specific microbubbles: Prospective multicenter study, Radiology, 232, pp. 799-809, (2004)

[9]

Blomley M.J., Albrecht T., Cosgrove D.O., Et al., Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508A: Early experience, Radiology, 10, pp. 409-416, (1999)

[10]

Lim A.K., Patel N., Eckersley R.J., Et al., Evidence for spleen-specific uptake of a microbubble contrast agent: A quantitative study in healthy volunteers, Radiology, 231, pp. 785-788, (2004)

← 1 2 3 →